AIDS and HIV Infections

Group co-leader: Maialen Ibarguren, M.D., Ph.D.

Donostialdea IHO E-mail MAIALEN.IBARGURENPINILLA@osakidetza.eus

Group co-leader: Francisco Carmona, M.D., Ph.D.

Donostialdea IHO E-mail FRANCISCODEASIS.CARMONADELATORRE@osakidetza.eus
Dr. Maialen Ibarguren Pinilla has a degree in Medicine and Surgery from the University of the Basque Country (UPV/EHU) in 2006 and a Doctor of Medicine from the same University with Cum Laude mention with the thesis “Viral load outbreaks in patients with HIV infection: magnitude of the problem, associated factors and risk of virological failure” in 2016. He has worked as an associate physician in the Infectious Diseases Service since 2012, combining healthcare activity with clinical research from the beginning, with special interest in area of HIV infection, nosocomial infections and infections by multidrug-resistant microorganisms. She has participated in more than 20 clinical trials as well as many other observational studies. Author or co-author of more than 200 communications at national and international conferences, author or collaborator in more than 50 publications in scientific journals and several book chapters. Experience as a teacher in various courses, seminars at the University of the Basque Country (UPV/EHU) and in the “International Master’s Degree in Pharmacotherapeutic Monitoring of HIV/AIDS Patients” taught by the University of Granada.

Dr. Ibarguren is co-head of the “Clinical and translational research group in infectious diseases” of the IIS Biogipuzkoa since 2023

Strategic Objectives

To improve the care provided to our patients through clinical research applied in a sustainable framework.

Lines of research

  • HIV
    • Effectiveness and efficiency of antiretroviral therapy (efficiency, virological failure, etc.).
    • New care modals.
    • Morbidity and mortality among the cohort.
    • Access to clinical trials.
  • HIV/HVC co-infection
    • Epidemiology.
    • Cirrhosis and its complications following sustained viral response.
  • Non-HIV infections
    • Infective endocarditis.
    • Prosthetic joint infection and other musculoskeletal infections.
    • Bacteraemia.
    • Sexually transmitted diseases. Pre-exposure treatment.
    • Access to clinical trials (Clostridium difficile, cellulitis, bacteraemia and other organ infections).
  • Non-HIV infections -COVID
    • Descriptive studies in the general population and in subpopulations (immunosuppressed).
    • Clinical prediction rules.
    • Access to clinical trials.
  • High-risk infectious diseases and organisation and training in High-Level Hospital Isolation Units (UAAN)

Team Members

Name Surname
Center E-mail
Ignacio Álvarez Rodríguez OSI Donostialdea ignacio.alvarezrodriguez@osakidetza.eus
Harkaitz Azkune Galparsoro OSI Donostialdea
Ana Bayona Carlos OSI Donostialdea ANA.BAYONACARLOS@osakidetza.eus
Maria Jesús Bustinduy Odriozola OSI Donostialdea majesus.bustinduyodriozola@osakidetza.eus
Xabier Camino Ortiz De Barrón OSI Donostialdea xabier.caminoortizdebarron@osakidetza.eus
Miguel Angel Goenaga Sánchez OSI Donostialdea miguelangel.goenagasanchez@osakidetza.eus
Jose Antonio Iribarren Loyarte OSI Donostialdea JOSEANTONIO.IRIBARRENLOYARTE@osakidetza.eus
Xabier Kortajarena Urkola OSI Donostialdea xabier.kortajarenaurkola@osakidetza.eus

Scientific Output

OPTIMIZAR LA ESTRATIFICACION DE RIESGO DE MUERTE EN PACIENTES CON COVID-19 MEDIANTE LA VALIDACION EXTERNA DE 2 MODELOS PREDICTIVOS PUBLICADOS: ANDC Y SEIMC
Código: 23BU202
Investigador Principal (IP): IGNACIO ALVAREZ RODRIGUEZ
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2022-10-10
Fecha de finalización: 2023-10-13
Importe Concedido: 8.400,00 €